Project Grant RF1NS132784

Award Date 9/6/23
Completion Date 8/31/26
Dollars Obligated $2.4M
Federal Grant Program
93.372
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a $2,554,313 federal Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant, which runs from Sep 1, 2023 to Aug 31, 2026, will support research to determine if targeted in vivo manipulations of local circuit control...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $652,497 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The 5-year grant, starting on May 1, 2025, will support research to define the neurological substrates of proximal upper extremity motor control and recovery after stroke. The project...
The National Science Foundation Division of Information and Intelligent Systems awarded a $999,710 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital, for research titled "COLLABORATIVE RESEARCH: NCS-FR: UNDERSTANDING THE NEUROPEPTIDE MODULATION OF BRAIN CIRCUITS BY ADVANCED NANOMATERIALS AND IMAGING." The award period is from September 1, 2021 to August 31, 2025. The grant supports research under the Computer and Information Science and...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $182,528 to The General Hospital Corporation (doing business as Massachusetts General Hospital) for a research project titled "Probing Network-Specific Cortical Connectivity by Combining Multifocal Transcranial Magnetic Stimulation with Electroencephalography". The research aims to develop and optimize methods for using multifocal...
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), provides $287,526 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to support the development and dissemination of the Connectome 2.0 ultra-high gradient 3T MRI scanner as a shared resource for advanced neuroimaging...
The Regents of the University of Michigan received a $137,586 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant funds the development of a reconfigurable neural interface platform that can integrate multiple sensor modalities, including electrophysiological recording, neurostimulation, and physiochemical...
This federal Project Grant award of $354,600.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), will support the development of novel methodologies for simultaneous, distributed perturbation of multiple cortical regions using patterned light in head-fixed mice. The goal is to infer how large-scale patterns of cortical activity underlie...
This $4.5 million project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke, under the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program, will fund research at Baylor College of Medicine from August 2022 to July 2025. The grant aims to advance understanding of how the neuromodulators acetylcholine and norepinephrine shape cortical responses and influence behavior. Researchers will study the spatial...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $459,250 federal Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The 2-year grant, running from August 15, 2023 to August 14, 2025, will fund research to investigate the state-dependent effects of transcranial alternating current stimulation (TACS) on theta-gamma cross-frequency coupling and fronto-parietal...
The University of Utah received a $2,856,242 project grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke to develop noninvasive targeted neuromodulation techniques. The grant is funded through the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program. Under the award, the University will perform research in non-human primates to determine effective stimulation parameters for modulating deep brain circuits...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,359,174 Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on the biophysical mechanisms of cortical microstimulation. The project aims to develop a more mechanistic understanding of how direct local electrical stimulation (DLES) affects brain function, with the goal of improving the design and implementation of more effective therapeutic neuromodulation approaches.

The research will combine single-cell electrophysiology, pharmacology, optical physiology, and computational modeling in both human and mouse cortex, both ex-vivo and in vivo, to identify the mechanisms by which DLES recruits different neuronal populations. The findings will be used to refine and validate a recurrent neuronal network model to predict cortical responses to novel stimuli and develop specific stimulation patterns to evoke desired neural outputs. This work is expected to catalyze novel, targeted, and mechanistically driven therapeutic approaches that could revolutionize stimulation-based treatment for neuropsychiatric disorders.

The project involves sub-awards to the University of Ottawa to support modeling and analysis, and to the Massachusetts Institute of Technology to conduct animal experiments, analyze human tissue physiology, and analyze human intracranial recording data. The award period runs from September 2023 through August 2026.

Generated 8/13/24, 8:33 AM